First Time Loading...

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 109.94 USD 0.61% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology... [ Read More ]

The intrinsic value of one JAZZ stock under the Base Case scenario is 336.97 USD. Compared to the current market price of 109.94 USD, Jazz Pharmaceuticals PLC is Undervalued by 67%.

Key Points:
JAZZ Intrinsic Value
Base Case
336.97 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Jazz Pharmaceuticals PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling JAZZ stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Jazz Pharmaceuticals PLC

Provide an overview of the primary business activities
of Jazz Pharmaceuticals PLC.

What unique competitive advantages
does Jazz Pharmaceuticals PLC hold over its rivals?

What risks and challenges
does Jazz Pharmaceuticals PLC face in the near future?

Has there been any significant insider trading activity
in Jazz Pharmaceuticals PLC recently?

Summarize the latest earnings call
of Jazz Pharmaceuticals PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jazz Pharmaceuticals PLC.

Provide P/S
for Jazz Pharmaceuticals PLC.

Provide P/E
for Jazz Pharmaceuticals PLC.

Provide P/OCF
for Jazz Pharmaceuticals PLC.

Provide P/FCFE
for Jazz Pharmaceuticals PLC.

Provide P/B
for Jazz Pharmaceuticals PLC.

Provide EV/S
for Jazz Pharmaceuticals PLC.

Provide EV/GP
for Jazz Pharmaceuticals PLC.

Provide EV/EBITDA
for Jazz Pharmaceuticals PLC.

Provide EV/EBIT
for Jazz Pharmaceuticals PLC.

Provide EV/OCF
for Jazz Pharmaceuticals PLC.

Provide EV/FCFF
for Jazz Pharmaceuticals PLC.

Provide EV/IC
for Jazz Pharmaceuticals PLC.

Show me price targets
for Jazz Pharmaceuticals PLC made by professional analysts.

What are the Revenue projections
for Jazz Pharmaceuticals PLC?

How accurate were the past Revenue estimates
for Jazz Pharmaceuticals PLC?

What are the Net Income projections
for Jazz Pharmaceuticals PLC?

How accurate were the past Net Income estimates
for Jazz Pharmaceuticals PLC?

What are the EPS projections
for Jazz Pharmaceuticals PLC?

How accurate were the past EPS estimates
for Jazz Pharmaceuticals PLC?

What are the EBIT projections
for Jazz Pharmaceuticals PLC?

How accurate were the past EBIT estimates
for Jazz Pharmaceuticals PLC?

Compare the revenue forecasts
for Jazz Pharmaceuticals PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jazz Pharmaceuticals PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jazz Pharmaceuticals PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jazz Pharmaceuticals PLC compared to its peers.

Compare the P/E ratios
of Jazz Pharmaceuticals PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Jazz Pharmaceuticals PLC with its peers.

Analyze the financial leverage
of Jazz Pharmaceuticals PLC compared to its main competitors.

Show all profitability ratios
for Jazz Pharmaceuticals PLC.

Provide ROE
for Jazz Pharmaceuticals PLC.

Provide ROA
for Jazz Pharmaceuticals PLC.

Provide ROIC
for Jazz Pharmaceuticals PLC.

Provide ROCE
for Jazz Pharmaceuticals PLC.

Provide Gross Margin
for Jazz Pharmaceuticals PLC.

Provide Operating Margin
for Jazz Pharmaceuticals PLC.

Provide Net Margin
for Jazz Pharmaceuticals PLC.

Provide FCF Margin
for Jazz Pharmaceuticals PLC.

Show all solvency ratios
for Jazz Pharmaceuticals PLC.

Provide D/E Ratio
for Jazz Pharmaceuticals PLC.

Provide D/A Ratio
for Jazz Pharmaceuticals PLC.

Provide Interest Coverage Ratio
for Jazz Pharmaceuticals PLC.

Provide Altman Z-Score Ratio
for Jazz Pharmaceuticals PLC.

Provide Quick Ratio
for Jazz Pharmaceuticals PLC.

Provide Current Ratio
for Jazz Pharmaceuticals PLC.

Provide Cash Ratio
for Jazz Pharmaceuticals PLC.

What is the historical Revenue growth
over the last 5 years for Jazz Pharmaceuticals PLC?

What is the historical Net Income growth
over the last 5 years for Jazz Pharmaceuticals PLC?

What is the current Free Cash Flow
of Jazz Pharmaceuticals PLC?

Financials

Balance Sheet Decomposition
Jazz Pharmaceuticals PLC

Current Assets 3.4B
Cash & Short-Term Investments 1.6B
Receivables 855.1m
Other Current Assets 954m
Non-Current Assets 8B
PP&E 235m
Intangibles 7.2B
Other Non-Current Assets 551.8m
Current Liabilities 1.5B
Accounts Payable 102.8m
Accrued Liabilities 792.8m
Other Current Liabilities 641.1m
Non-Current Liabilities 6.1B
Long-Term Debt 5.1B
Other Non-Current Liabilities 1B
Efficiency

Earnings Waterfall
Jazz Pharmaceuticals PLC

Revenue
3.8B USD
Cost of Revenue
-435.6m USD
Gross Profit
3.4B USD
Operating Expenses
-2.7B USD
Operating Income
659.4m USD
Other Expenses
-244.5m USD
Net Income
414.8m USD

Free Cash Flow Analysis
Jazz Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

JAZZ Profitability Score
Profitability Due Diligence

Jazz Pharmaceuticals PLC's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
54/100
Profitability
Score

Jazz Pharmaceuticals PLC's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

JAZZ Solvency Score
Solvency Due Diligence

Jazz Pharmaceuticals PLC's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
35/100
Solvency
Score

Jazz Pharmaceuticals PLC's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 192 USD with a low forecast of 122.21 USD and a high forecast of 241.5 USD.

Lowest
Price Target
122.21 USD
11% Upside
Average
Price Target
192 USD
75% Upside
Highest
Price Target
241.5 USD
120% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

JAZZ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

JAZZ Price
Jazz Pharmaceuticals PLC

1M 1M
-12%
6M 6M
-18%
1Y 1Y
-24%
3Y 3Y
-35%
5Y 5Y
-13%
10Y 10Y
-21%
Annual Price Range
109.94
52w Low
107.1
52w High
145.35
Price Metrics
Average Annual Return 6.73%
Standard Deviation of Annual Returns 17.43%
Max Drawdown -43%
Shares Statistics
Market Capitalization 6.8B USD
Shares Outstanding 62 350 000
Percentage of Shares Shorted 6.04%

JAZZ Return Decomposition
Main factors of price return

What is price return decomposition?

JAZZ News

Other Videos

Last Important Events
Jazz Pharmaceuticals PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Jazz Pharmaceuticals PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC

Country

Ireland

Industry

Pharmaceuticals

Market Cap

6.8B USD

Dividend Yield

0%

Description

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. The company is headquartered in Dublin, Dublin and currently employs 3,200 full-time employees. The company went IPO on 2012-01-18. The firm is focused on developing and commercializing products that address unmet medical needs. The firm has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The firm's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD). The firm also commercializes Prialt, an intrathecally administered infusion of ziconotide, approved by the FDA for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or intrathecal morphine.

Contact

DUBLIN
DUBLIN
Fifth Fl, Waterloo Exchange, Waterloo Road
+35316347800.0
https://www.jazzpharma.com/

IPO

2012-01-18

Employees

3 200

Officers

Co-Founder, Chairman & CEO
Mr. Bruce C. Cozadd
President & COO
Ms. Reneé D. Galá
Non-Executive Employee
Mr. Daniel N. Swisher Jr.
Executive VP and Global Head of Research & Development
Dr. Robert Iannone M.D.
Executive VP & CFO
Mr. Philip L. Johnson
Senior VP & Chief Accounting Officer
Ms. Patricia Carr
Show More
VP & Head of Investor Relations
Ms. Andrea N. Flynn Ph.D.
Executive VP & Chief Legal Officer
Ms. Neena M. Patil J.D.
Senior VP of Corporate Development & Chief Transformation Officer
Dr. George Christopher Eliades Ph.D.
Executive VP & Chief People Officer
Ms. Heidi Manna
Show Less

See Also

Discover More
What is the Intrinsic Value of one JAZZ stock?

The intrinsic value of one JAZZ stock under the Base Case scenario is 336.97 USD.

Is JAZZ stock undervalued or overvalued?

Compared to the current market price of 109.94 USD, Jazz Pharmaceuticals PLC is Undervalued by 67%.